Auto-Injector Market Size

  • Report ID: 3511
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Auto-Injector Market Size

Auto-injectors Market size was over USD 9.27 billion in 2024 and is poised to cross USD 41.88 billion by the end of 2037, witnessing more than 12.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of auto-injectors is estimated at USD 10.18 billion. The reason behind the growth is impelled by the rising cases of rheumatoid arthritis. Hand disabilities can make it more difficult for individuals with rheumatoid arthritis (RA) to use syringes to give medication as part of their therapy therefore, auto-injectors could potentially mitigate this problem as by using them patients can administer etanercept a medicine used to treat rheumatoid arthritis on their own, in the comfort of their own homes, using an auto-injection pen-like device. Globally, more than 17 million cases of rheumatoid arthritis were reported in 2020.

The growing government initiatives to increase awareness are believed to fuel the market growth. For instance, on June 2023 the Medicines and Healthcare Products Regulatory Agency (MHRA), in collaboration with allergy awareness advocates, released new guidelines outlining the most recent safety recommendations for what to do in the event of anaphylaxis and offered guidance on how to use adrenaline auto-injectors.


Auto-injectors Market Overview (1)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3511
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of auto-injectors is estimated at USD 10.18 billion.

The auto-injectors market size was over USD 9.27 billion in 2024 and is poised to cross USD 41.88 billion by the end of 2037, witnessing more than 12.3% CAGR during the forecast period i.e., between 2025-2037. Rising cases of rheumatoid arthritis and the growing government initiatives to increase awareness will drive the market growth.

North America industry is estimated to account for largest revenue share 45% by 2037, impelled by rising investment in the healthcare sector in the region.

The major players in the market are Scandinavian Health Ltd., AbbVie, Inc., Amgen, Owen Mumford, Ypsomed, Biogen Idec, Mylan N.V., Pfizer, Inc., Sanofi, and Stevanato Group.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample